These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prevalence of multidrug-resistant gram-negative bacilli producing extended-spectrum β-lactamases (ESBLs) and ESBL genes in solid organ transplant recipients. Men TY; Wang JN; Li H; Gu Y; Xing TH; Peng ZH; Zhong L Transpl Infect Dis; 2013 Feb; 15(1):14-21. PubMed ID: 23013385 [TBL] [Abstract][Full Text] [Related]
8. Clinical Risk Factors for Death Caused by Extended-Spectrum Beta-Lactamase: Producing Bacteria. Mita Y; Shigemura K; Osawa K; Kitagawa K; Kotaki T; Shirakawa T; Miyara T; Fujisawa M Urol Int; 2019; 102(2):205-211. PubMed ID: 30602152 [TBL] [Abstract][Full Text] [Related]
9. The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea. Ahn JY; Ann HW; Jeon Y; Ahn MY; Oh DH; Kim YC; Kim EJ; Song JE; Jung IY; Kim MH; Jeong W; Ku NS; Jeong SJ; Choi JY; Yong D; Song YG; Kim JM BMC Infect Dis; 2017 May; 17(1):327. PubMed ID: 28468622 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH). Lim CL; Lee W; Lee AL; Liew LT; Nah SC; Wan CN; Chlebicki MP; Kwa AL BMC Infect Dis; 2013 Nov; 13():523. PubMed ID: 24195651 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy. Kang CI; Chung DR; Ko KS; Peck KR; Song JH; Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875 [TBL] [Abstract][Full Text] [Related]
12. Ertapenem for treatment of extended-spectrum beta-lactamase-producing and multidrug-resistant gram-negative bacteraemia. Lye DC; Wijaya L; Chan J; Teng CP; Leo YS Ann Acad Med Singap; 2008 Oct; 37(10):831-4. PubMed ID: 19037516 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for 28-day mortality in elderly patients with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia. Ku NS; Kim YC; Kim MH; Song JE; Oh DH; Ahn JY; Kim SB; Kim HW; Jeong SJ; Han SH; Kim CO; Song YG; Kim JM; Choi JY Arch Gerontol Geriatr; 2014; 58(1):105-9. PubMed ID: 23988261 [TBL] [Abstract][Full Text] [Related]
14. A rapid and inexpensive protocol to screen for third generation cephalosporin-resistant and non-fermenting Gram-negative rods directly in positive blood cultures. Parmeland L; Bourru T; Kyungu V; Rousseau N; Gleize M; De Beauvoir C; Pecquet M Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115428. PubMed ID: 34174522 [TBL] [Abstract][Full Text] [Related]
15. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia. Tamma PD; Han JH; Rock C; Harris AD; Lautenbach E; Hsu AJ; Avdic E; Cosgrove SE; Clin Infect Dis; 2015 May; 60(9):1319-25. PubMed ID: 25586681 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology and outcome of antimicrobial resistance to gram-negative pathogens in bacteriuric kidney transplant recipients. Delmas-Frenette C; Dorais M; Tavares-Brum A; Frenette C; Yang B; Medani S; Duclos A; Rouleau D; Mawad H; Barama A; Cardinal H Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28486744 [TBL] [Abstract][Full Text] [Related]
17. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan. Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342 [TBL] [Abstract][Full Text] [Related]
18. Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy. Yang CC; Wu CH; Lee CT; Liu HT; Chen JB; Chiu CH; Chen CH; Chuang FR Int J Infect Dis; 2014 Nov; 28():3-7. PubMed ID: 25200093 [TBL] [Abstract][Full Text] [Related]
19. Low relapse rate of urinary tract infections from extended-spectrum beta-lactamase-producing bacteria in young children. Hyun HS; Kim JH; Cho MH; Park E; Ha IS; Cheong HI; Kang HG Pediatr Nephrol; 2019 Nov; 34(11):2399-2407. PubMed ID: 31270617 [TBL] [Abstract][Full Text] [Related]
20. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Xiao T; Yang K; Zhou Y; Zhang S; Ji J; Ying C; Shen P; Xiao Y Antimicrob Resist Infect Control; 2019; 8():144. PubMed ID: 31467670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]